|
|
| (6 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| {| class="wikitable"
| | |
| !
| |
| !Stress Cardiomyopathy
| |
| !Anterior Wall MI
| |
| |-
| |
| |[[Chest pain]] and [[dyspnea]] as presenting symptoms
| |
| |✔
| |
| |✔
| |
| |-
| |
| |[[ST elevation]] in [[precordial leads]]
| |
| |✔
| |
| |✔
| |
| |-
| |
| |Peak [[CK-MB]] value
| |
| |<50 U/L
| |
| |↑↑↑
| |
| |-
| |
| |6-month outcome
| |
| |Favorable outcome
| |
| |Higher rates of:
| |
| * Death
| |
| * Cardiac death
| |
| * [[Reinfarction]]
| |
| * Rehospitalization
| |
| * Major cardiac events
| |
| |}
| |
| Stress cardiomyopathy must also be differentiated from Takotsubo-like syndrome caused by medical conditions, such as [[pheochromocytoma]]:<ref name="pmid23058349">{{cite journal |vauthors=Mikail N, Hess S, Jesel L, El Ghannudi S, El Husseini Z, Trinh A, Ohlmann P, Morel O, Imperiale A |title=Takotsubo and Takotsubo-like syndrome: a common neurogenic myocardial stunning pathway? |journal=Int. J. Cardiol. |volume=166 |issue=1 |pages=248–50 |year=2013 |pmid=23058349 |doi=10.1016/j.ijcard.2012.09.116 |url=}}</ref>
| |
| {| class="wikitable"
| |
| !
| |
| !Stress Cardiomyopathy
| |
| !Takotsobu-like Syndrome
| |
| |-
| |
| |[[Chest pain]] mimicking [[MI]]
| |
| |✔
| |
| |✔
| |
| |-
| |
| |[[EKG]] findings ([[ST elevation]])
| |
| |✔
| |
| |✔
| |
| |-
| |
| |Positive [[cardiac enzymes]]
| |
| |✔
| |
| |✔
| |
| |-
| |
| |[[LV]] regional dysfunction
| |
| |✔
| |
| |✔
| |
| |-
| |
| |Patient profile
| |
| |Post-menopausal women
| |
| |Younger patients with less female predominance
| |
| |-
| |
| |[[Catecholamine]] levels
| |
| |Transient elevation
| |
| |Constantly elevated
| |
| |-
| |
| |Complications
| |
| |
| |
| |Higher rate of complications, including:
| |
| * [[Cardiogenic shock]]
| |
| * [[Heart failure]]
| |
| * Low [[Ejection fraction|ejection fraction (EF)]]
| |
| |}
| |